Targeting of the protein interaction site between FAK and IGF-1R

Donghang Zheng1, Elena Kurenova, Deniz Ucar

  • 1Department of Surgery, University of Florida, Gainesville, FL, USA.

Insights

Researchers identified a key interaction between focal adhesion kinase (FAK) and insulin-like growth factor-1 receptor (IGF-1R) crucial for cancer cell survival. A novel compound was discovered that disrupts this FAK/IGF-1R binding, offering a potential new cancer therapy strategy.

Area of Science:

  • Molecular biology
  • Cancer research
  • Drug discovery

Background:

  • The interaction between focal adhesion kinase (FAK) and insulin-like growth factor-1 receptor (IGF-1R) is vital for cancer cell survival.
  • Targeting this interaction presents a novel therapeutic strategy for cancer treatment.

Purpose of the Study:

  • To elucidate the specific domains involved in FAK and IGF-1R interaction.
  • To identify small molecules capable of disrupting the FAK/IGF-1R binding site.

Main Methods:

  • Pull-down assays using GST-tagged FAK fragments and His-tagged IGF-1R intracellular fragments.
  • Co-localization studies in pancreatic cells with overexpressed FAK-NT2 domain.
  • Computational modeling for predicting binding configurations and screening small molecules.

Main Results:

  • The FAK-NT2 (amino acids 127-243) domain directly interacts with the N-terminal region of the IGF-1R intracellular domain.
  • FAK-NT2 domain co-localizes with IGF-1R in pancreatic cells.
  • A lead compound was identified that effectively disrupts the FAK/IGF-1R interaction.

Conclusions:

  • The FAK-NT2 domain is a critical interaction site with IGF-1R.
  • Small molecule-based disruption of the FAK/IGF-1R interaction is a viable therapeutic approach.
  • The identified lead compound shows promise for developing new anti-cancer drugs targeting this pathway.

Related Concept Videos

Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Assembly of Signaling Complexes01:30

Assembly of Signaling Complexes

Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...